Page 27 - Read Online

bilobar liver metastases from digestive endocrine tumors: a safe SD, Pitt HA. Neuroendocrine hepatic metastases: does aggressive
approach for radical resection. Ann Surg 2008;247:659-65. management improve survival? Ann Surg 2005;241:776-83;
22. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, discussion 783-5.
Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer 37. Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin
A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, NE. Liver metastases of neuroendocrine carcinomas: interventional
Lang H, Obed A, Schlitt HJ. Right portal vein ligation combined treatment via transarterial embolization, chemoembolization and
with in situ splitting induces rapid left lateral liver lobe hypertrophy thermal ablation. Eur J Radiol 2009;72:517-28.
enabling 2-staged extended right hepatic resectionin small-for-size 38. Toumpanakis C, Meyer T, Caplin ME. Cytotoxic treatment including
settings. Ann Surg 2012;255:405-14. embolization/chemoembolization for neuroendocrine tumours. Best
23. Coppa J, Pulvirenti A, Schiavo M, Romito R, Collini P, Di Pract Res Clin Endocrinol Metab 2007;21:131-44.
Bartolomeo M, Fabbri A, Regalia E, Mazzaferro V. Resection 39. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the
versus transplantation for liver metastases from neuroendocrine management of neuroendocrine hepatic metastases. J Vasc Interv
tumors. Transpantl Proc 2001;33:1537-9. Radiol 2006;17:1235-49.
24. Le Treut YP, Gregoire E, Klempnauer J, Belghiti J, Jouve E, Lerut 40. Del Prete M, Fiore F, Modica R, Marotta V, Marciello F, Ramundo
J, Castaing D, Soubrane O, Boillot O, Mantion G, Homayounfar V, Di Sarno A, Carratù A, De Luca di Roseto C, Tafuto S,
K, Bustamante M, Azoulay D, Wolf P, Krawczyk M, Pascher A, Tatangelo F, Baldelli R, Colao A, Faggiano A, on the behalf of the
Suc B, Chiche L, de Urbina JO, Mejzlik V, Pascual M, Lodge JP, Multidisciplinary Group for NeuroEndocrine Tumors of Naples.
Gruttadauria S, Paye F, Pruvot FR, Thorban S, Foss A, Adam R; For Hepatic arterial embolization in patients with neuroendocrine
ELITA. Liver transplantation for neuroendocrine tumors in Europe- tumors. J Exp Clin Cancer Res 2014;33:43.
results and trends in patient selection: a 213-case European Liver 41. Carrasco CH, Charnsangavej C, Ajani J, Samaan NA, Richli W,
Transplant Registry study. Ann Surg 2013;257:807-15. Wallace S. The carcinoid syndrome: palliation by hepatic artery
25. Sher LS, Levi DM, Wecsler JS, Lo M, Petrovic LM, Groshen S, Ji L, embolization. AJR Am J Roentgenol 1986;147:149-54.
Uso TD, Tector AJ, Hamilton AS, Marsh JW, Schwartz ME. Liver 42. Pericleous M, Caplin ME, Tsochatzis E, Yu D, Morgan-rowe L
transplantation for metastatic neuroendocrine tumors: outcomes and and Toumpanakis C. Hepatic artery embolization in advanced
prognostic variables. J Surg Oncol 2015;112:125-32. neuroendocrine tumors: efficacy and long-term outcomes. Asia Pac
26. Bonaccorsi-Riani E, Apestegui C, Jouret-Mourin A, Sempoux C, J Clin Oncol 2016;12:61-9.
Goffette P, Ciccarelli O, Borbath I, Hubert C, Gigot JF, Hassoun Z, 43. Kim YH, Ajani JA, Carrasco CH, Dumas P, Richli W, Lawrence D,
Lerut J. Liver transplantation and neuroendocrine tumors: lessons Chuang V, Wallace S. Selective hepatic arterial chemoembolization
from a single centre experience and from the literature review. for liver metastases in patients with carcinoid tumor or islet cell
Transpl Int 2010;23:668-78. carcinoma. Cancer Invest 1999;17:474-8.
27. Frilling A, Malago M, Weber F, Paul A, Nadalin S, Sotiropoulos GC, 44. Kennedy A, Bester L, Salem R, Sharma RA, Parks R, Ruszniewski
Cicinnati V, Beckebaum S, Bockisch A, Mueller-Brand J, Hofmann P, NET-Liver-Metastases Consensus Conference. Role of hepatic
M, Schmid KW, Gerken G,Broelsch CE. Liver transplantation for intra-arterial therapies in metastatic neuroendocrine tumours (NET):
patients with metastatic endocrine tumors: single-center experience guidelines from the NET-Liver-Metastases Consensus Conference.
with 15 patients. Liver Transpl 2006;12:1089-96. HPB (Oxford) 2015;17:29-37.
28. Florman S, Toure B, Kim L, Gondolesi G, Roayaie S, Krieger N, 45. Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC,
Fishbein T, Emre S, Miller C, Schwartz M. Liver transplantation for McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic
neuroendocrine tumors. J Gastrointest Surg 2004;8:208-12. arterial embolization and chemoembolization for the treatment of
29. Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, patients with metastatic neuroendocrine tumors: variables affecting
Nashan B, Lang H, Klempnauer J, Manns MP, Boeker KH. Ki67, response rates and survival. Cancer 2005;104:1590-602.
E-cadherin, and p53 as prognostic indicators of long-term outcome 46. Schell SR, Camp ER, Caridi JG, Hawkins IF Jr. Hepatic artery
after liver transplantation for metastatic neuroendocrine tumors. embolization for control of symptoms, octreotide requirements, and
Transplantation 2002;73:386-94. tumor progression in metastatic carcinoid tumors. J Gastrointest
30. Gedaly R, Daily MF, Davenport D, McHugh PP, Koch A, Angulo Surg 2002;6:664-70.
P, Hundley JC. Liver transplantation for the treatment of liver 47. Dong XD, Carr BI. Hepatic artery chemoembolization for the
metastases from neuroendocrine tumors: an analysis of the UNOS treatment of liver metastases from neuroendocrine tumors: a long-
database. Arch Surg 2011;146:953-8. term follow-up in 123 patients. Med Oncol 2011;28 suppl 1:S286-90.
31. Steward MJ, Warbey VS, Malhotra A, Caplin ME, Buscombe JR, 48. Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen
Yu D. Neuroendocrine tumors: role of interventional radiology in H, Rilling WS, Quebbeman EJ, Agarwal DM, Pitt HA. Hepatic
therapy. Radiographics 2008;28:1131-45. neuroendocrine metastases: chemo- or bland embolization? J
32. Henn AR, Levine EA, McNulty W, Zagoria RJ. Percutaneous Gastrointest Surg 2008;12:1951-60.
radiofrequency ablation of hepatic metastases for symptomatic relief of 49. Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting
neuroendocrine syndromes. AJR Am J Roentgenol 2003;181:1005-10. C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H,
33. Norlén O, Stålberg P, Zedenius J, Hellman P. Outcome after resection Overton C, Jones B, Salem R. Radioembolization for unresectable
and radiofrequency ablation of liver metastases from small intestinal neuroendocrine hepatic metastases using resin 90Y-microspheres:
neuroendocrine tumours. Br J Surg 2013; 100:1505-14. early results in 148 patients. Am J Clin Oncol 2008;31:271-9.
34. Ho AS, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, Brown 50. King J, Quinn R, Glenn D, Janssen J, Tong D, Liaw W, Morris DL.
DB. Roentgenol Long-term outcome after chemoembolization and Radioembolization with selective internal radiation microspheres
embolization of hepatic metastatic lesions from neuroendocrine for neuroendocrine liver metastases. Cancer 2008;113:921-9.
tumors. AJR Am J Roentgenol 2007;188:1201-7. 51. Whitney R, Valek V, Fages JF, Garcia A, Narayanan G, Tatum
35. Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, C, Hahl M, Martin RC 2nd. Transarterial chemoembolization
Rosemurgy AS, Yeatman TJ, Carey L, Duhaine L, Kvols LK. and selective internal radiation for the treatment of patients with
Improved outcome with cytoreduction versus embolization for metastatic neuroendocrine tumors: a comparison of efficacy and
symptomatic hepatic metastases of carcinoid and neuroendocrine cost. Oncologist 2011;16:594-601.
tumors. Ann Surg Oncol 2006; 13:572-81. 52. Crowder CD, Grabowski C, Inampudi S, Sielaff T, Sherman CA,
36. Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson Batts KP. Selective internal radiation therapy-induced extrahepatic
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ August 17, 2016 ¦ 301